Systemic vasculitis during the course of systemic sclerosis: Report of 12 cases and review of the literature

Medicine (United States)

Volumn 92, Issue 1, 2013, Pages 1-9

  Quéméneur, Thomas ^a   Mouthon, Luc ^b   Cacoub, Patrice ^c   Meyer, Olivier ^d   Michon Pasturel, Ulrique ^e   Vanhille, Philippe ^a   Hatron, Pierre Yves ^f   Guillevin, Loïc ^b   Hachulla, Eric ^f  

^a Hospital of Valenciennes   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d BICHAT HOSPITAL   (France)

^e SAINT JOSEPH HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PENICILLAMINE;

ANCA ASSOCIATED VASCULITIS; CELL PROLIFERATION; DRUG MEGADOSE; FOLLOW UP; FRANCE; HUMAN; IMMUNE COMPLEX NEPHRITIS; LUNG FIBROSIS; MICROSCOPIC POLYANGIITIS; MIXED CRYOGLOBULINEMIA VASCULITIS; PLASMAPHERESIS; PRIORITY JOURNAL; REMISSION; REVIEW; SJOEGREN SYNDROME; SKIN BIOPSY; SYSTEMIC SCLEROSIS; SYSTEMIC VASCULITIS; VASCULITIS;

ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIRHEUMATIC AGENTS; BIOLOGICAL MARKERS; BIOPSY; CRYOGLOBULINEMIA; CYCLOPHOSPHAMIDE; FEMALE; FRANCE; HUMANS; MIDDLE AGED; PENICILLAMINE; SCLERODERMA, SYSTEMIC; VASCULITIS;

EID: 84871924038     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e31827781fd     Document Type: Review

References (52)

1. Akimoto S, Ishikawa O, Tamura T, Miyachi Y. Antineutrophilcytoplasmic autoantibodies in patients with systemic sclerosis.Br J Dermatol. 1996;134:407-410. (Pubitemid 26090936)
2. Akkara Veetil BM, Schimmer BM. A case of limited systemic sclerosiswith p-ANCA, complicated by multiple cerebral hemorrhages.Rheumatol Int. 2009;29:325-329.
3. Anders HJ, Wiebecke B, Haedecke C, Sanden S, Combe C, SchlondorffD. MPO-ANCA-positive crescentic glomerulonephritis: a distinct entityof scleroderma renal disease? Am J Kidney Dis. 1999;33:e3.
4. Arad U, Balbir-Gurman A, Doenyas-Barak K, Amit-Vazina M, Caspi D,Elkayam O. Anti-neutrophil antibody associated vasculitis in systemicsclerosis. Semin Arthritis Rheum. 2011;41:223-229.
5. Arnaud L, Huart A, Plaisier E, Francois H, Mougenot B, Tiev K,Kettaneh A, Ronco P, Rougier JP. ANCA-related crescenticglomerulonephritis in systemic sclerosis: revisiting the "normotensivescleroderma renal crisis." Clin Nephrol. 2007;68:165-170. (Pubitemid 47377339)
6. Avouac J, Airo P, Dieude P Caramaschi P, Tiev K, Diot E, Sibilia J,Cappelli S, Granel B, Vacca A, Wipff J, Meyer O, Kahan A,Matucci-Cerinic M, Allanore Y. Associated autoimmune diseasesin systemic sclerosis define a subset of patients with milder disease:results from 2 large cohorts of European Caucasian patients.J Rheumatol. 2010;37:608-614.
7. Bienaimé F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP.D-Penicillamine-induced ANCA-associated crescenticglomerulonephritis in Wilson disease. Am J Kidney Dis. 2007;50:821-825. (Pubitemid 47588548)
8. Buskila D, Langevitz P, Lee P. The frequency of cryoglobulinaemia insystemic sclerosis (scleroderma). Br J Rheumatol. 1990;29:234. (Pubitemid 20194032)
9. Cannon PJ, Hassar M, Case DB, Casarella WJ, Sommers SC, LeRoy EC.The relationship of hypertension and renal failure in scleroderma(progressive systemic sclerosis) to structural and functionalabnormalities of the renal cortical circulation. Medicine (Baltimore).1974;53:1-46.
10. Carvajal I, Bernis C, Sanz P, Garcia A, Garcia-Vadillo A, Traver JA.Antineutrophil cytoplasmic autoantibodies (ANCA) and systemicsclerosis. Nephrol Dial Transplant. 1997;12:576-577. (Pubitemid 27105639)
11. Casari S, Haeney M, Farrand S, Herrick A. Antineutrophil cytoplasmicantibodies a "red flag" in patients with systemic sclerosis. J Rheumatol.2002;29:2666-2667. (Pubitemid 35416986)
12. Cheung G, Chew G, Wyndham R, Peters M, Riminton S.Myeloperoxidase- antineutrophil cytoplasmic antibody seroconversionand fulminant vasculitis in Scl-70-positive scleroderma. Intern Med J.2007;37:205-207.
13. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence andprevalence of systemic sclerosis: a systematic literature review. SeminArthritis Rheum. 2008;37:223-235.
14. Endo H, Hosono T, Kondo H. Antineutrophil cytoplasmicautoantibodies in 6 patients with renal failure and systemic sclerosis.J Rheumatol. 1994;21:864-870. (Pubitemid 24168670)
15. Gross WL, Schmitt WH, Csernok E. Antineutrophil cytoplasmicautoantibody- associated diseases: a rheumatologist's perspective. Am JKidney Dis. 1991;18:175-179.
16. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O,Thibult N, Casassus P. Prognostic factors in polyarteritis nodosa andChurg-Strauss syndrome. A prospective study in 342 patients. Medicine(Baltimore). 1996;75:17-28. (Pubitemid 26041085)
17. Guilpain P, Chereau C, Goulvestre C, Servettaz A, Montani D, Tamas N,Pagnoux C, Hachulla E, Weill B, Guillevin L, Mouthon L, Batteux F.The oxidation induced by antimyeloperoxidase antibodies triggersfibrosis in microscopic polyangiitis. Eur Respir J. 2011;37:1503-1513.
18. Helfrich DJ, Banner B, Steen VD, Medsger TA Jr. Normotensive renalfailure in systemic sclerosis. Arthritis Rheum. 1989;32:1128-1134.
19. Herrera-Esparza R, Aguilar JL, Saucedo A, Gonzalez I, Lopez-Robles E,Avalos-Diaz E. Scleroderma with type III glomerulonephritis andMPO-ANCA antibodies in the serum. J Eur Acad Dermatol Venereol.2005;19:617-620. (Pubitemid 41742847)
20. Hidalgo-Tenorio C, Càliz R, Gallego M, Jaimez L, Jimenez-Alonzo J.Systemic sclerosis, pulmonary fibrosis and anti-MPO antibodies.Clinical Rheumatology. 2005;24:658-660. (Pubitemid 41644345)
21. Hillis GS, Khan IH, Simpson JG, Rees AJ. Scleroderma,D-penicillamine treatment, and progressive renal failure associated withpositive antimyeloperoxidase antineutrophil cytoplasmic antibodies.Am J Kidney Dis. 1997;30:279-281. (Pubitemid 27330347)
22. Husson JM, Druet P, Contet A, Fiessinger JN, Camilleri JP. Systemicsclerosis and cryoglobulinemia. Clin Immunol Immunopathol.1976;6:77-82.
23. Invernizzi F, Galli M, Serino G, Monti G, Meroni PL, Granatieri C,Zanussi C. Secondary and essential cryoglobulinemias. Frequency,nosological classification, and long-term follow-up. Acta Haematol.1983;70:73-82. (Pubitemid 13076858)
24. Kamen DL, Wigley FM, Brown AN. Antineutrophil cytoplasmicantibody- positive crescentic glomerulonephritis in sclerodermaVadifferent kind of renal crisis. J Rheumatol. 2006;33:1886-1888. (Pubitemid 44373230)
25. Katrib A, Sturgess A, Bertouch JV. Systemic sclerosis andantineutrophil cytoplasmic autoantibody-associated renal failure.Rheumatol Int. 1999;19:61-63. (Pubitemid 30025690)
26. Kiraz S, Simsek H, Ertenli I, Benekli M, Kadayifci A. Antineutrophilcytoplasmic antibodies in systemic sclerosis. Clin Rheumatol. 1996;15:519-520.
27. Kumakura S, Ishikura H, Kondo M, Murakawa Y, Kobayashi S.Hemophagocytosis associated with MPO-ANCA positive vasculitis insystemic sclerosis. Clin Exp Rheumatol. 2002;20:411-414. (Pubitemid 35012580)
28. Kyndt X, Ducq P, Bridoux F, Reumaux D, Makdassi R, Gheerbrant JD,Vanhille P. Extracapillary glomerulonephritis with antimyeloperoxidaseantibodies in 2 patients with systemic sclerodermatreated with penicillamine D. Presse Med. 1999;28:67-70.
29. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TAJr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis):classification, subsets and pathogenesis. J Rheumatol. 1988;15:202-205. (Pubitemid 18073738)
30. Le Thi Huong D, Gatfosse M, Papo T, Beaufils H, Faucher C, Frances C,Godeau P. Wegener's granulomatosis and CREST syndrome. Br JRheumatol. 1994;33:1087-1088.
31. Locke IC, Worrall JG, Leaker B, Black CM, Cambridge G.Autoantibodies to myeloperoxidase in systemic sclerosis. J Rheumatol.1997;24:86-89. (Pubitemid 27059863)
32. Maes B, Van Mieghem A, Messiaen T, Kuypers D, Van Damme B,Vanrenterghem Y. Limited cutaneous systemic sclerosis associated withMPO-ANCA positive renal small vessel vasculitis of the microscopicpolyangiitis type. Am J Kidney Dis. 2000;36:E16.
33. Marlier S, Gisserot O, Yao N, Hecht M, Paris JF, Carli P, Chagnon A.Extra-capillary glomerulonephritis induced by D-penicillamine therapy.Presse Med. 1999;28:689-690.
34. Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL. Prevalence ofantineutrophil cytoplasmic antibodies in a large inception cohort ofpatients with connective tissue disease. Ann Intern Med. 1997;126:866-873. (Pubitemid 27232627)
35. Mimura I, Hori Y, Matsukawa T, Uozaki H, Tojo A, Fujita T.Noncrescentic ANCA-associated renal crisis in systemic sclerosis.Clin Nephrol. 2008;70:183-185.
36. Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A.Autoantibodies against neutrophil cytoplasm components in systemiclupus erythematosus and in hydralazine-induced lupus. Clin ExpImmunol. 1990;81:380-383. (Pubitemid 20273659)
37. Oddis CV, Eisenbeis CH Jr, Reidbord HE, Steen VD, Medsger TA Jr.Vasculitis in systemic sclerosis: association with Sjogren's syndromeand the CREST syndrome variant. J Rheumatol. 1987;14:942-948.
38. Omote A, Muramatsu M, Sugimoto Y, Hosono S, Murakami R,Tanaka H, Watanabe Y, Sano H, Kato K. Myeloperoxidase-specificanti-neutrophil cytoplasmic autoantibodiesVrelated scleroderma renalcrisis treated with double-filtration plasmapheresis. Intern Med.1997;36:508-513. (Pubitemid 27349311)
39. Reveille JD, Solomon DH. American College of Rheumatology Ad HocCommittee of Immunologic Testing Guidelines. Evidence-basedguidelines for the use of immunologic tests: anticentromere, Scl-70, andnucleolar antibodies. Arthritis Rheum. 2003;49:399-412.
40. Rho YH, Choi SJ, Lee YH, Ji JD, Song GG. Scleroderma associatedwith ANCA-associated vasculitis. Rheumatol Int. 2006;26:465-468.
41. Ruffatti A, Sinico RA, Radice A, Ossi E, Cozzi F, Tonello M, GrypiotisP, Todesco S. Autoantibodies to proteinase 3 and myeloperoxidase insystemic sclerosis. J Rheumatol. 2002;29:918-923. (Pubitemid 34493493)
42. Salliot C, Mouthon L, Ardizzone M, Sibilia J, Guillevin L, GottenbergJE, Mariette X. Sjogren's syndrome is associated with and notsecondary to systemic sclerosis. Rheumatology. 2007;46:321-326. (Pubitemid 46189795)
43. Sol EB, Bonkain F, Vande Houtte K, Dratwa M. Systemic sclerodermaassociated to a glomerulonephritis with anti-MPO antibodies: a casereport and literature review. Rev Med Brux. 2008;29:559-567.
44. Steen VD, Medsger TA. Changes in causes of death in systemicsclerosis, 1972-2002. Ann Rheum Dis. 2007;66:940-944. (Pubitemid 46999798)
45. Teixeira L, Mouthon L, Mahr A, Berezne A, Agard C, Mehrenberger M,Noel LH, Trolliet P, Frances C, Cabane J, Guillevin L. Mortality and riskfactors of scleroderma renal crisis: a French retrospective study of50 patients. Ann Rheum Dis. 2008;67:110-116.
46. Tomioka M, Hinoshita F, Miyauchi N, Akiyama Y, Saima S, Hiroe M.ANCA-related crescentic glomerulonephritis in a patient withscleroderma without marked dermatological change and malignanthypertension. Intern Med. 2004;43:496-502. (Pubitemid 38979412)
47. Tzelepis GE, Kokosi M, Tzioufas A, Toya SP, Boki KA, Zormpala A,Moutsopoulos HM. Prevalence and outcome of pulmonary fibrosis inmicroscopic polyangiitis. Eur Respir J. 2010;36:116-121.
48. Vazquez-Del Mercado M, Mendoza-Topete A, Best-Aguilera CR,Garcia-De La Torre I. Diffuse alveolar hemorrhage in limited cutaneoussystemic sclerosis with positive perinuclear antineutrophil cytoplasmicantibodies. J Rheumatol. 1996;23:1821-1823. (Pubitemid 26342462)
49. Villaverde V, Balsa A, Cabezas JA, Fernandez-Prada M, Torre A, MolaEM. Normotensive renal failure in a patient with systemic sclerosis andp-antineutrophil cytoplasmic autoantibodies which developed intoPaget's disease of bone after immunosuppressive therapy.Rheumatology. 1999;38:190-191. (Pubitemid 29507247)
50. Wong M, Ranganath VK, Clements PJ. Antineutrophil cytoplasmicantibody- positive digital necrosis in a patient with limited systemicsclerosis. J Rheumatol. 2010;37:214-215.
51. Wutzl AL, Foley RN, O'Driscoll BR, Reeve RS, Chisholm R, HerrickAL. Microscopic polyangiitis presenting as pulmonary-renal syndromein a patient with long-standing diffuse cutaneous systemic sclerosis andantibodies to myeloperoxidase. Arthritis Rheum. 2001;45:533-536. (Pubitemid 33140589)
52. Yamashita K, Yorioka N, Kyuden Y, Naito T, Tanji C, Ueda C, Usui K,Shigemoto K, Harada S, Yamakido M. A case of CREST syndromeand myeloperoxidase-specific anti-neutrophil cytoplasmicautoantibody-associated glomerulonephritis. Clin Nephrol. 2000;5:296-300. (Pubitemid 30204938)